Latest Global Active Pharmaceutical Ingredient RFP & RFQ

Price Registration for Eventual Acquisition of Compounded Medicines.

Alfacalcidol

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V for Various Active Ingredients/Combinations with the Possibility of Conclusion at any Time as Part of the So-Called Open House Procedure

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V for Various Active Ingredients/Combinations with the Possibility of Conclusion at any Time as Part of the So-Called Open House Procedure

Supply of Raw Materials, Reagents and Solvents for the Production of Api (Active Pharmaceutical Ingredient)

Open House Drug Discount Agreements for the Active Ingredient Ranibizumab, as a Pre-Filled Syringe, Atc S01La04

Open House Drug Discount Agreements for the Active Ingredient Apremilast, Atc L04Aa32

Open House Drug Discount Agreements for the Active Ingredients Formoterol, Glycopyrronium Bromide and Beclometasone, Atc R03Al09

Open House Drug Discount Agreements for the Active Ingredient Maraviroc, Atc J05Ax09

Open House Drug Discount Agreements for the Active Ingredient Aflibercept, with a Potency of 40 Mg/Ml, Atc S01La05